We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) ended the recent trading session at $538.83, demonstrating a +0.34% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.04%. Meanwhile, the Dow gained 0.07%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Shares of the company have depreciated by 0.28% over the course of the past month, outperforming the Medical sector's loss of 4.31% and lagging the S&P 500's gain of 1.05%.
The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company is forecasted to report an EPS of $1.76, showcasing a 10% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $2.21 billion, reflecting a 14.53% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.88 per share and a revenue of $8.15 billion, signifying shifts of +20.49% and +14.36%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Intuitive Surgical, Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.09% higher. At present, Intuitive Surgical, Inc. boasts a Zacks Rank of #3 (Hold).
Investors should also note Intuitive Surgical, Inc.'s current valuation metrics, including its Forward P/E ratio of 78.06. For comparison, its industry has an average Forward P/E of 28.57, which means Intuitive Surgical, Inc. is trading at a premium to the group.
Meanwhile, ISRG's PEG ratio is currently 4.18. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments was holding an average PEG ratio of 2.46 at yesterday's closing price.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 53, which puts it in the top 22% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
Intuitive Surgical, Inc. (ISRG - Free Report) ended the recent trading session at $538.83, demonstrating a +0.34% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.04%. Meanwhile, the Dow gained 0.07%, and the Nasdaq, a tech-heavy index, lost 0.05%.
Shares of the company have depreciated by 0.28% over the course of the past month, outperforming the Medical sector's loss of 4.31% and lagging the S&P 500's gain of 1.05%.
The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company is forecasted to report an EPS of $1.76, showcasing a 10% upward movement from the corresponding quarter of the prior year. At the same time, our most recent consensus estimate is projecting a revenue of $2.21 billion, reflecting a 14.53% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $6.88 per share and a revenue of $8.15 billion, signifying shifts of +20.49% and +14.36%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Intuitive Surgical, Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.09% higher. At present, Intuitive Surgical, Inc. boasts a Zacks Rank of #3 (Hold).
Investors should also note Intuitive Surgical, Inc.'s current valuation metrics, including its Forward P/E ratio of 78.06. For comparison, its industry has an average Forward P/E of 28.57, which means Intuitive Surgical, Inc. is trading at a premium to the group.
Meanwhile, ISRG's PEG ratio is currently 4.18. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments was holding an average PEG ratio of 2.46 at yesterday's closing price.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 53, which puts it in the top 22% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.